GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortress Biotech Inc (FRA:CNB1) » Definitions » 5-Year Yield-on-Cost %

Fortress Biotech (FRA:CNB1) 5-Year Yield-on-Cost % : 0.00 (As of May. 23, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Fortress Biotech 5-Year Yield-on-Cost %?

Fortress Biotech's yield on cost for the quarter that ended in Mar. 2024 was 0.00.


The historical rank and industry rank for Fortress Biotech's 5-Year Yield-on-Cost % or its related term are showing as below:



FRA:CNB1's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.615
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Fortress Biotech's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Fortress Biotech's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fortress Biotech's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fortress Biotech's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Fortress Biotech's 5-Year Yield-on-Cost % falls into.



Fortress Biotech 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Fortress Biotech is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Fortress Biotech  (FRA:CNB1) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Fortress Biotech 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Fortress Biotech's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fortress Biotech (FRA:CNB1) Business Description

Traded in Other Exchanges
Address
1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Fortress Biotech (FRA:CNB1) Headlines

No Headlines